Molecular epidemiology of tuberculosis after declining incidence, New York City, 2001-2003

Epidemiology and Infection

Volumn 135, Issue 4, 2007, Pages 634-643

  Driver, C R ^a   Kreiswirth, B ^b   Macaraig, M ^a   Clark, C ^a   Munsiff, S S ^a,c   Driscoll, J ^d   Zhao, B ^a  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BACTERIUM ISOLATION; CLUSTER ANALYSIS; CONTROLLED STUDY; EPIDEMIC; FEMALE; GENOTYPE; HOMELESSNESS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; MYCOBACTERIUM TUBERCULOSIS; POPULATION RESEARCH; SUBSTANCE ABUSE; SYMPTOMATOLOGY; TUBERCULOSIS; UNITED STATES;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; NEW YORK CITY; RISK FACTORS; TUBERCULOSIS;

EID: 34247475713     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268806007278     Document Type: Article

References (36)

1. CDC. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons - Florida and New York, 1988-1991. Morbidity and Mortality Weekly Report 1991; 40: 129-131.
2. Edlin BR, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency symdrome. New England Journal of Medicine 1992; 326: 1514-1521.
3. Pearson ML, et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis: A risk to patients and health care workers. Annals of Internal Medicine 1992; 117: 191-196.
4. Frieden TR, et al. A multi-institutional outbreak of highly drug-resistant tuberculosis: Epidemiology and clinical outcomes. Journal of the American Medical Association 1996; 276: 1229-1235.
5. Valway SE, et al. Outbreak of multi-drug-resistant tuberculosis in a New York State Prison, 1991. American Journal of Epidemiology 1994; 140: 113-122.
6. Frieden TR, et al. The molecular epidemiology of tuberculosis in New York City: The importance of nosocomial transmission and laboratory error. Tubercle and Lung Disease 1996; 77: 407-413.
7. Frieden TR, et al. The emergence of drug-resistant tuberculosis in New York City. New England Journal of Medicine 1993; 328: 521-526.
8. Munsiff SS, et al. Molecular epidemiology of multidrug-resistant tuberculosis, New York City, 1995-1997. Emerging Infectious Diseases 2002; 8: 1230-1238.
9. Tornieporth NG, et al. Tuberculosis among foreign-born persons in New York City, 1992-1994: Implications for tuberculosis control. International Journal of Tuberculosis and Lung Diseases 1997; 1: 528-535.
10. Friedman CR, et al. Transmission of multidrug-resistant tuberculosis in a large urban setting. American Journal of Respiratory Critical Care Medicine 1995; 152: 355-359.
11. Magnani J, et al. Molecular epidemiology of tuberculosis among eight hospitals in New York City, 1996-1997. International Journal of Infectious Diseases 2001; 5: 126-132.
12. Geng E, et al. Changes in the transmission of tuberculosis in New York City from 1990 to 1999. New England Journal of Medicine 2002; 346: 1453-1458.
13. Kamerbeek J, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. Journal of Clinical Microbiology 1997; 35: 907-914.
14. Kwara A, et al. Evaluation of the epidemiologic utility of secondary typing methods for differentiation of Mycobacterium tuberculosis isolates. Journal of Clinical Microbiology 2003; 41: 2683-2685.
15. Clark CM, et al. Universal genotyping in tuberculosis control program, New York City, 2001-2003. Emerging Infectious Diseases 2006; 12: 719-724.
16. Alland D, et al. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. New England Journal of Medicine 1994; 330: 1710-1716.
17. Ellis BA, et al. National Tuberculosis Genotyping and Surveillance Network Work Group. Molecular epidemiology of tuberculosis in a sentinel surveillance population. Emerging Infectious Diseases 2002; 8: 1197-1209.
18. Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 13-22.
19. Zeger SL, Liang K-Y. Longitudinal data analysis for discrete and continous outcomes. Biometrics 1986; 42: 121-130.
20. Brudey K, et al. Mycobacterium tuberculosis complex genetic diversity: Mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiology 2006; 6: 23.
21. Munsiff SS, et al. Persistence of a hightly resistant strain of tuberculosis in New York City during 1990-1999. Journal of Infectious Diseases 2003; 188: 356-363.
22. Plikaytis BB, et al. Multiplex PCR assay specific for the mulidrug-resistant strain W of Mycobacterium tuberculosis. Journal of Clinical Microbiology 1994; 32: 1542-1546.
23. Friedman CR, et al. Widespread dissemination of a drug-susceptible strain of Mycobacterium tuberculosis. Journal of Infectious Diseases 1997; 176: 478-484.
24. Coronado VG, et al. Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: Epidemiologic and restriction fragment length polymorphism analysis. Journal of Infectious Diseases 1993; 168: 1052-55.
25. Nivin B, et al. A continuing outbreak of multidrug-resistant tuberculosis, with transmission in a hospital nursery. Clinical Infectious Diseases 1998; 26: 303-307.
26. Shafer RW, et al. Temporal trends and transmission patterns during the emergence of multidrug-resistant tuberculosis in New York City: A molecular epidemiologic assessment. Journal of Infectious Diseases 1995; 171: 170-176.
27. Small PM, et al. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. New England Journal of Medicine 1993; 328: 1137-1144.
28. Vynnycky E, et al. The effect of age and study duration on the relationship between 'clustering' of DNA fingerprint patterns and the proportion of tuberculosis disease attributable to redent transmission. Epidemiology and Infection 2001; 126: 43-62.
29. van Soolingen D. Molecular epidemiology of tuberculosis and other mycobacterial infections: Main methodologies and achievements. Journal of Internal Medicine 2001; 249: 1-26.
30. Glynn JR, Vynnycky E, Fine PE. Influence of sampling on estimates of clustering and recent transmission of Mycobacterium tuberculosis derived from DNA fingerprinting techniques. American Journal of Epidemiology 1999; 149: 366-371.
31. van Soolingen D, et al. Molecular epidemiology of tuberculosis in the Netherlands: A nationwide study from 1993 through 1997. Journal of Infectious Diseases 1999; 180: 726-736.
32. McConkey SJ, et al. Prospective use of molecular typing of Mycobacterium tuberculosis by use of restriction fragment-length polymorphism in a public tuberculosis-control program. Clinical Infectious Diseases 2002; 34: 612-619.
33. Bishai WR, et al. Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapy. Journal of the American Medical Association 1998; 280: 1679-1684.
34. Barnes PF, et al. Patterns of tuberculosis transmission in Central Los Angeles. Journal of the American Medical Associationv 1997; 278: 1159-1163.
35. Jasmer RM, et al. A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991-1997. Annals of Internal Medicine 1999; 130: 971-978.
36. CDC. Tuberculosis transmission in a homeless shelter population - New York, 2000-2003. Morbidity and Mortality Weekly Report 2005; 54: 149-152.